AcelRx's lead product candidate, the ARX-01 Sufentanil NanoTab PCA System, which is currently in Phase 3 clinical development, is designed to solve the problems associated with post-operative
intravenous patient-controlled analgesia which has been shown to cause harm to patients following surgery because of the side effects of morphine, the invasive IV route of delivery and the inherent potential for programming and delivery errors associated with the complexity of infusion pumps.
Opioid use for post-operative
pain relief can delay or prolong surgical recovery," said Robert J.
Devise corrective measures for pipeline projects by understanding Post-Operative
Pain pipeline depth and focus of Indication therapeutics.
Established in 1988, Biodermis has been recognized for its innovative contributions to the scar management and post-operative
care industry for more than 25 years.
CR845 is a highly selective, peripherally-restricted kappa opioid receptor agonist currently in development for the treatment of post-operative
Pain Therapeutics under Investigation by Universities/Institutes
ARX-01 is a novel drug/device combination product candidate designed for use in hospital settings to provide non-invasive patient-controlled analgesia and maximize patient satisfaction with post-operative
Cohen, Symphony Medical chief executive officer said, "Physicians recognize the acute and long term implications related to post-operative
AF including the potential for higher incidences of post-op stroke and the development of chronic atrial fibrillation.
Ondansetron, a selective blocking agent of the hormone serotonin, is an FDA-approved active ingredient that is commonly used in tablet form to prevent chemotherapy- and radiation-induced and post-operative
nausea and vomiting.
Patients treated with ketorolac had a reduced risk of post-operative
respiratory depression, a reduced risk of myocardial infarction, and a reduced risk of allergic reactions.
Twenty years later, nearly 600,000 valves have been implanted globally without any post-operative
structural failure and with outstanding clinical results.
In pilot studies, patients given a single intravenous dose experienced sustained post-operative
pain relief for up to 24 hours without gastrointestinal side effects.